Carbohydrate and fluid intake affect the saliva flow rate and IgA response to cycling.
OBJECTIVE
The purpose of this study was to examine the effect of regular CHO beverage ingestion and restricted fluid intake on various salivary parameters during prolonged cycle exercise.


METHODS
In a randomized block design, 15 recreationally active men cycled for 2 h at 60% VO2max on three occasions, separated by 1 wk. On the CHO and placebo (PLA) treatments, subjects consumed either a glucose (60 g x L(-1)) or placebo drink before (400 mL), during (150 mL every 15 min), and after (400 mL) the exercise. On the restricted fluid intake (RFI) treatment subjects were given a total of 200 mL of placebo fluid to take as desired every 15-min during the exercise. Timed, unstimulated saliva samples were collected preexercise, at 1, 1.5, and 2 h of exercise and at 1 h postexercise. Blood samples were obtained from a subset of 8 subjects preexercise, postexercise, and at 1 h postexercise.


RESULTS
Postexercise plasma glucose levels were 18% and 20% lower on the PLA and RFI treatments, respectively, compared with the CHO treatment (P < 0.01). Saliva flow rates were significantly higher on the CHO treatment compared with the RFI treatment at 1.5 h and 2 h of exercise (P < 0.01 and P < 0.05, respectively). Salivary IgA (s-IgA) concentration was significantly lower on the CHO treatment compared with the RFI treatment throughout the exercise (P < 0.05). No other differences were seen between treatments for either saliva flow rate or s-IgA concentration. Neither s-IgA secretion rate, alpha-amylase activity, nor alpha-amylase secretion rate were affected by treatment.


CONCLUSIONS
These findings suggest that CHO and fluid intake influence the s-IgA and saliva flow rate response to prolonged submaximal exercise.
Bishop
N C
NC
School of Sport and Exercise Sciences, University of Birmingham, Edgbaston, England.
Blannin
A K
AK
Armstrong
E
E
Rickman
M
M
Gleeson
M
M
D000328:Adult; D001628:Beverages; D001642:Bicycling / Q000502:physiology*; D004040:Dietary Carbohydrates / Q000494:pharmacology*; D006801:Humans; D007070:Immunoglobulin A / Q000378:metabolism; D008297:Male; D012463:Saliva / Q000737:chemistry*; D012472:Salivation / Q000187:drug effects / Q000502:physiology*; D000516:alpha-Amylases / Q000378:metabolism
D004040:Dietary Carbohydrates; D007070:Immunoglobulin A; D000516:alpha-Amylases